Aarti Drugs Limited has reported total income of Rs. 622.22 crores during the quarter ended June 30, 2022.
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
With this, the company can start selling Ibuprofen in the European markets.
Company raises the annual revenue guidance from mid-teens to high teens
Orion to receive an upfront payment of USD 290 million
Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
The combined company will be able to better serve both our global and regional customers with local production
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Subscribe To Our Newsletter & Stay Updated